News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
123,768 Results
Type
Article (6279)
Company Profile (56)
Press Release (117432)
Multimedia
Podcasts (24)
Webinars (7)
Section
Business (40836)
Career Advice (1331)
Deals (5496)
Drug Delivery (18)
Drug Development (14289)
Employer Resources (112)
FDA (2496)
Job Trends (3962)
News (59037)
Policy (4098)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (3)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (755)
Accelerated approval (16)
ADA (14)
Adcomms (7)
Allergies (40)
Alliances (10276)
ALS (100)
Alzheimer's disease (551)
Antibody-drug conjugate (ADC) (141)
Approvals (2666)
Artificial intelligence (261)
ASCO (71)
Autoimmune disease (93)
Automation (23)
Bankruptcy (32)
Belgium (1)
Best Places to Work (3409)
BIO (9)
BIOSECURE Act (5)
Biosimilars (59)
BioSpace Insights (34)
Biotechnology (32)
Bladder cancer (54)
Brain cancer (30)
Breast cancer (167)
Cancer (1725)
Cardiovascular disease (153)
Career advice (1136)
Career pathing (39)
CAR-T (97)
CDC (11)
CDMO (30)
Celiac Disease (1)
Cell therapy (269)
Cervical cancer (19)
Clinical research (13748)
Collaboration (850)
Commercialization (3)
Company closure (2)
Compensation (253)
Complete response letters (16)
COVID-19 (456)
CRISPR (41)
C-suite (577)
Cystic fibrosis (66)
Data (2310)
Decentralized trials (3)
Denatured (2)
Depression (64)
Dermatology (24)
Diabetes (213)
Diagnostics (1737)
Digital health (26)
Diversity (6)
Diversity, equity & inclusion (21)
Drug discovery (113)
Drug pricing (26)
Duchenne muscular dystrophy (130)
Earnings (12331)
Editorial (27)
Employer branding (14)
Employer resources (94)
Events (17242)
Executive appointments (519)
FDA (3624)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (13)
Frontotemporal dementia (11)
Funding (764)
Gene editing (86)
Generative AI (20)
Gene therapy (248)
GLP-1 (208)
Government (735)
Grass and pollen (1)
Guidances (81)
Healthcare (4997)
Hematology (51)
HIV (29)
Huntington's disease (19)
IgA nephropathy (50)
Immunology and inflammation (65)
Immuno-oncology (32)
Indications (65)
Infectious disease (569)
Inflammatory bowel disease (43)
Inflation Reduction Act (1)
Influenza (42)
Intellectual property (72)
Interviews (241)
IPO (2646)
IRA (2)
Job creations (622)
Job search strategy (913)
JPM (14)
Kidney cancer (4)
Labor market (66)
Layoffs (124)
Leadership (32)
Legal (651)
Licensing (5)
Liver cancer (21)
Longevity (12)
Lung cancer (207)
Lymphoma (126)
Machine learning (26)
Management (35)
Manufacturing (360)
Marketing (3)
MASH (64)
Medical device (2897)
Medtech (2978)
Mergers & acquisitions (3345)
Metabolic disorders (416)
mRNA (63)
Multiple sclerosis (45)
NASH (4)
Netherlands (2)
Neurodegenerative disease (155)
Neuropsychiatric disorders (42)
Neuroscience (1106)
NextGen: Class of 2026 (1888)
Non-profit (2189)
Now hiring (13)
Obesity (138)
Opinion (118)
Ovarian cancer (62)
Pain (77)
Pancreatic cancer (84)
Parkinson's disease (115)
Partnered (15)
Patents (123)
Patient recruitment (338)
Peanut (17)
People (14507)
Pharmaceutical (12)
Pharmacy benefit managers (6)
Phase 1 (4094)
Phase 2 (6020)
Phase 3 (5027)
Pipeline (3109)
Policy (70)
Postmarket research (310)
Preclinical (1184)
Press Release (39)
Prostate cancer (97)
Psychedelics (9)
Radiopharmaceuticals (97)
Rare diseases (397)
Real estate (1124)
Recruiting (55)
Regulatory (4242)
Reports (21)
Research institute (892)
Resumes & cover letters (243)
Rett syndrome (23)
RNA editing (8)
RSV (12)
Schizophrenia (56)
Series A (147)
Series B (92)
Service/supplier (3)
Sickle cell disease (42)
Special edition (7)
Spinal muscular atrophy (70)
Sponsored (17)
Startups (801)
State (1)
Supply chain (31)
Tariffs (9)
The Weekly (22)
Vaccines (289)
Venture capital (34)
Weight loss (76)
Women's health (52)
Worklife (16)
Date
Today (41)
Last 7 days (123)
Last 30 days (513)
Last 365 days (7728)
2026 (5258)
2025 (8155)
2024 (8605)
2023 (9787)
2022 (10731)
2021 (11752)
2020 (11324)
2019 (11464)
2018 (8198)
2017 (5744)
2016 (5143)
2015 (5264)
2014 (3500)
2013 (2572)
2012 (2595)
2011 (2756)
2010 (1917)
Location
Africa (256)
Alabama (21)
Alaska (4)
Arizona (84)
Arkansas (8)
Asia (7641)
Australia (1414)
California (3707)
Canada (930)
China (455)
Colorado (161)
Connecticut (201)
Delaware (170)
Europe (16407)
Florida (585)
Georgia (136)
Hawaii (3)
Idaho (17)
Illinois (376)
India (31)
Indiana (128)
Iowa (9)
Japan (131)
Kansas (22)
Kentucky (18)
Louisiana (15)
Maine (12)
Maryland (533)
Massachusetts (2877)
Michigan (100)
Minnesota (189)
Mississippi (6)
Missouri (99)
Montana (14)
Nebraska (12)
Nevada (55)
New Hampshire (40)
New Jersey (1011)
New Mexico (11)
New York (945)
North Carolina (575)
North Dakota (3)
Northern California (1838)
Ohio (176)
Oklahoma (14)
Oregon (14)
Pennsylvania (534)
Puerto Rico (4)
Rhode Island (15)
South America (291)
South Carolina (24)
Southern California (1515)
Tennessee (127)
Texas (570)
United States (13780)
Utah (142)
Vermont (1)
Virginia (107)
Washington D.C. (32)
Washington State (520)
West Virginia (3)
Wisconsin (55)
123,768 Results for "missing recruiter 542037".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Career Advice
Why a missed promotion isn’t always about you
A missed promotion can feel like a verdict on your potential. But people and organizations do not always develop at the same pace. Executive coach Angela Justice breaks down what a missed promotion is actually telling you—and what it isn’t.
August 12, 2026
·
3 min read
·
Angela Justice
Cancer
Regeneron misses again as melanoma combo bows to Merck’s Keytruda in Phase 3
The late-stage miss shakes analyst confidence in Regeneron’s clinical execution, according to BMO Capital Markets, also noting last year’s Phase 3 failure in chronic obstructive pulmonary disease.
May 18, 2026
·
2 min read
·
Tristan Manalac
Earnings
Moderna maintains 10% growth target despite Phase 3 norovirus miss
Moderna’s norovirus vaccine failed in a Phase 3 trial, but the company still has faith in an ambitious revenue growth target thanks to ex-U.S. vaccine sales and a unanimous FDA adcomm win for mFLUSIVA.
July 31, 2026
·
4 min read
·
Gabrielle Masson
Lymphoma
AbbVie, Genmab’s Bispecific Misses Key Overall Survival Endpoint in Phase III Lymphoma Study
Despite the late-stage miss, analysts maintained confidence in the Epkinly program, with Truist Securities saying the result “doesn’t waver our optimism” regarding the bispecific antibody’s ongoing frontline trial.
January 19, 2026
·
2 min read
·
Tristan Manalac
Career Advice
6 Things Candidates Do That Make It Harder for Recruiters To Get Them Jobs
Recruiters can play a significant role in biopharma professionals getting hired, especially in an employer-driven job market. However, when working with them, candidates need to avoid making six key mistakes, from waiting too long to ask for help to prematurely contacting hiring companies.
March 19, 2026
·
4 min read
·
Angela Gabriel
Earnings
Merck’s $10.8B Prometheus deal delivers another win—plus a Phase 2b miss
The anti-TL1A antibody from Merck’s 2023 Prometheus buy delivered positive mid-stage results in a skin condition but failed in a certain type of lung disease, the Big Pharma revealed alongside second-quarter earnings.
August 4, 2026
·
3 min read
·
Gabrielle Masson
Layoffs
Heidelberg Pharma Misses Out on Royalty Payment, Plans 75% Workforce Cut
The company was awaiting $70 million from HealthCare Royalty but missed an agreed-upon payment condition.
September 26, 2025
·
1 min read
·
Dan Samorodnitsky
Pancreatic cancer
Elicio crashes on midstage pancreatic cancer miss but will advance to Phase 3
Elicio Therapeutics’ investigational cancer immunotherapy failed to meet the primary endpoint of disease-free survival in a Phase 2 trial—a result the company attributed mostly to a disproportionate number of patients with higher residual disease.
June 15, 2026
·
2 min read
·
Heather McKenzie
Brain cancer
Imvax Heads to FDA With 6-Month Survival Gain in Glioblastoma, Despite Endpoint Miss
While Imvax’s autologous immunotherapy IGV-001 missed the primary endpoint of progression-free survival in a Phase IIb trial, the company will request a meeting with the FDA to discuss next steps for “synergistic” treatment.
December 2, 2025
·
2 min read
·
Dan Samorodnitsky
Rare diseases
Mirum, Incyte bolster case for approval in rare bone disease despite mid-stage miss
While falling short of statistical significance, Incyte and Mirum Pharmaceuticals’ ALK2 inhibitor showed a “clear benefit” in reducing abnormal bone formation in a Phase 2 study of fibrodysplasia ossificans progressiva.
June 16, 2026
·
2 min read
·
Tristan Manalac
1 of 12,377
Next
